SCHEMBL16252541

SCHEMBL16252541

CC(C)C(=O)N1CCN(CC(=O)N(C)C)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
MTNR1B P49286 1/20 0.39
POLB P06746 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
PIK3CD O00329 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
CHRNB3 Q05901 1/20 0.38
CHRNA6 Q15825 1/20 0.38
DRD4 P21917 1/20 0.38
CYP2C19 P33261 1/20 0.36
F10 P00742 1/20 0.35
DRD2 P14416 1/20 0.35
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
RAB9A P51151 1/20 0.34
HRH2 P25021 1/20 0.34
HRH1 P35367 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24585217 0.85 ALDH1A1 (0.44) ALDH1A1MTNR1BCHRNB2CHRNA3CHRNA4
SCHEMBL16254571 0.79 ALDH1A1 (0.64) ALDH1A1PIK3CDDRD4KDM4E
SCHEMBL12233455 0.79 HSD17B10 (0.44) ALDH1A1MTNR1BPOLBRXFP1PIK3CD
SCHEMBL2935834 0.79 ALDH1A1 (0.64) ALDH1A1POLBDRD4F10DRD2
SCHEMBL28131331 0.79 PIK3CD (0.46) ALDH1A1MTNR1BPOLBRXFP1PIK3CD
SCHEMBL12304483 0.78 ALDH1A1 (0.53) ALDH1A1POLBCHRNB2CHRNA4DRD4
SCHEMBL21004046 0.78 ALDH1A1 (0.62) ALDH1A1POLBDRD4F10DRD2
SCHEMBL1911532 0.77 MAPT (0.52) ALDH1A1MTNR1BCHRNB2CHRNA3CHRNA4
SCHEMBL15043685 0.77 ALDH1A1 (0.59) ALDH1A1DRD4DRD2KDM4ENPC1
SCHEMBL23568316 0.76 PIK3CD (0.43) ALDH1A1MTNR1BPOLBRXFP1PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9586956-B2 Isoquinoline and naphthyridine derivatives GENENTECH, INC. (US) 2017-03-07 US disclosed
US-9586956-B2 Isoquinoline and naphthyridine derivatives GENENTECH, INC. (US) 2017-03-07 US disclosed
US-20140343036-A1 ISOQUINOLINE AND NAPHTHYRIDINE DERIVATIVES GENENTECH, INC. (US) 2014-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343036-A1 ISOQUINOLINE AND NAPHTHYRIDINE DERIVATIVES NQO1, NDUFC2, NDUFV2 ALDH1A1 958/4885MTNR1B 1031/4885POLB 418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.